Kenes is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programs. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organization contributing to improving health outcomes by:
Championing best practice in CME
Maintaining and improving standards
Mentoring and educating
Working in collaboration with critical stakeholders
After participating in this educational activity, participants should be able to:
Discuss the factors involved for the significant increase of the number of patients with MDS
Identify recent findings relating to biology, diagnosis and treatment of MDS
Integrate the methods taught in the morphology workshops and implement them in the field
Establish an international network of clinicians, scientists and educators specializing in MDS.
The 12th International Symposium on Myelodysplastic Syndromes (MDS 2013) has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
The 12th International Symposium on Myelodysplastic Syndromes (MDS 2013) is designated for a maximum of, or up to, 18 (eighteen) European CME credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS): www.uems.net
American Medical Association (AMA)
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Royal College of Physicians and Surgeons of Canada
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: www.royalcollege.ca.
EUROPEAN HEMATOLOGY ASSOCIATION (EHA) CME
The program of the 12th International Symposium on Myelodysplastic Syndromes has been reviewed and approved for CME accreditation by the European Hematology Association CME Unit. The EHA-CME Unit has approved this educational activity for a maximum number of 18 CME credits. Each physician should only claim credits for time that she/he actually spent in the educational activity.
DEUTSCHE ÄRZTEKAMMER BERLIN
The 12th International Symposium on Myelodysplastic Syndromes is accredited by the Deutsche Ärztekammer Berlin. The following credits will be granted to participants: 3 CME points/ half a day.
CME CREDIT BREAKDOWN
Each participant should claim only those hours of credit that he/she actually spent in the educational activity. Faculty should only claim time spent participating as a learner, time spent teaching should not be included in claimed credits. See the meeting program for credits per session.
Credits per Day
Wednesday, May 8, 2013
Thursday, May 9, 2013
Friday, May 10, 2013
Saturday, May 11, 2013
CERTICATE OF ATTENDANCE (NON-CME)
A non-CME certificate of attendance may be collected on-site.
HOW TO RECEIVE YOUR CME/CPD CERTIFICATE
Your CME/CPD certificate will be delivered electronically after completing the educational evaluation and credit claiming procedure. The process will take 5-10 minutes. We thank you for your feedback as it is an important part of the CME/CPD accreditation process and helps improve future educational offerings. All evaluation responses are anonymous; your name will be requested for the credit claiming and certificate process only.
European Accreditation Council for Continuing Medical Education (UEMS/EACCME)
Before June 17, 2013:
1. Follow the link in the email notification sent at the end of the event, or visit the CME/CPD Accreditation page under the Scientific Program menu.
2. Login with your unique User ID (included in your registration email)
3. Complete the online evaluation with your important feedback
4. Indicate the number of hours you actually attended
5. Your CME/CPD certificate will be automatically emailed to the address provided
6. Retain the certificate for your personal records
European Hematology Association (EHA) CME
All participants may print a European Hematology Association CME System approved CME certificate indicating the number of EHA-CME Credit Points awarded, directly from the online system on the CME section of the EHA website atwww.ehaweb.org. The system will be available after the event.
DISCLOSURE & RESOLUTION OF PERSONAL CONFLICTS OF INTEREST
In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor in CME/CPD activities, those in control of the educational content must disclose potential or actual conflicts of interest, whether due to a financial or other relationship. Presenters have been asked to include a disclosure slide at the beginning of their presentation. Participants will be asked on the evaluation to assess the objectivity and independence of the event. Disclosure information per faculty is also available in the EHA-CME disclosure database at:http://cme.ehaweb.org/.
COMMERCIAL SUPPORT DISCLOSURE
This symposium is supported, in part, by educational grants and in-kind support from industry. All support is managed in strict accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support. Appropriate acknowledgement of all supporting organizations is made to participants prior to the educational activity in the program guide, on the congress website, and with signage during the congress.
The information provided during this CME activity is for continuing medical education purposes only. It is not meant to substitute for the independent medical judgment of a health care provider relative to diagnostic and treatment options for a specific patient’s medical condition.